Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $750.2050 (0.83%) ($750.2050 - $752.0100) on Mon. May. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 37 | Latest Price | $750.2050(0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN declines -2.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(45%) DIA(31%) SPLV(29%) VYM(29%) | Factors Impacting REGN price | REGN will decline at least -0.79% in a week (0% probabilities). VXX(-23%) VIXM(-18%) TBT(-5%) ACES(-5%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | 1.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $778.29 | 5 Day Moving Average | $748.67(0.21%) | 10 Day Moving Average | $760.29(-1.33%) | 20 Day Moving Average | $778.29(-3.61%) | To recent high | -9.6% | To recent low | 1.9% | Market Cap | $79.543b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |